{"entity":{"type":"insider","cik":"0001492805","url":"/insider/0001492805","json_url":"/insider/0001492805.json","name":"Palombella Vito J.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":11,"first":"2013-06-21","last":"2022-08-05","span_basis":"filed_date"},"name_variants":[{"name":"Palombella Vito J.","source":"filing","n_filings":11,"first_seen":"2013-06-21","last_seen":"2022-08-05"}],"transactions":[{"id":6252192,"accession":"0001209191-22-044671","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-044671","line_url":"/filing/0001209191-22-044671#line-1","is_derivative":false,"issuer_cik":"0001492805","issuer_name":"Surface Oncology, Inc.","issuer_ticker":"SURF","issuer_name_source":null,"issuer_url":"/issuer/0001492805","owner_cik":"0001492805","owner_name":"Palombella Vito J.","owner_display_name":"Palombella Vito J.","owner_url":"/insider/0001492805","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4463.0,"shares_display":"4,463","price_per_share":1.72,"price_display":"1.72","price_state":"stated","total_value":7676.36,"total_display":"7,676.36","total_whole":"7,676","shares_owned_after":87212.0,"shares_owned_after_display":"87,212","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-03","filed_date":"2022-08-05","scope":"insider"},{"id":6423268,"accession":"0001209191-22-003398","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-003398","line_url":"/filing/0001209191-22-003398#line-1","is_derivative":false,"issuer_cik":"0001492805","issuer_name":"Surface Oncology, Inc.","issuer_ticker":"SURF","issuer_name_source":null,"issuer_url":"/issuer/0001492805","owner_cik":"0001492805","owner_name":"Palombella Vito J.","owner_display_name":"Palombella Vito J.","owner_url":"/insider/0001492805","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26325.0,"shares_display":"26,325","price_per_share":6.1,"price_display":"6.10","price_state":"stated","total_value":160582.5,"total_display":"160,582.50","total_whole":"160,583","shares_owned_after":53675.0,"shares_owned_after_display":"53,675","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-21","filed_date":"2022-01-14","scope":"insider"},{"id":8827020,"accession":"0001209191-15-053771","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-053771","line_url":"/filing/0001209191-15-053771#line-1","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001492805","owner_name":"Palombella Vito J.","owner_display_name":"Palombella Vito J.","owner_url":"/insider/0001492805","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4737.0,"shares_display":"4,737","price_per_share":10.97,"price_display":"10.97","price_state":"stated","total_value":51964.89,"total_display":"51,964.89","total_whole":"51,965","shares_owned_after":868.0,"shares_owned_after_display":"868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-15","filed_date":"2015-06-16","scope":"insider"},{"id":7003598,"accession":"0001209191-14-076042","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-076042","line_url":"/filing/0001209191-14-076042#line-2","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001492805","owner_name":"Palombella Vito J.","owner_display_name":"Palombella Vito J.","owner_url":"/insider/0001492805","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4737.0,"shares_display":"4,737","price_per_share":16.3171,"price_display":"16.32","price_state":"stated","total_value":77294.1027,"total_display":"77,294.10","total_whole":"77,294","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-15","filed_date":"2014-12-16","scope":"insider"},{"id":6420835,"accession":"0001209191-14-071692","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-071692","line_url":"/filing/0001209191-14-071692#line-2","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001492805","owner_name":"Palombella Vito J.","owner_display_name":"Palombella Vito J.","owner_url":"/insider/0001492805","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4736.0,"shares_display":"4,736","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":71040.0,"total_display":"71,040.00","total_whole":"71,040","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-26","filed_date":"2014-11-28","scope":"insider"},{"id":7074893,"accession":"0001209191-14-056122","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-056122","line_url":"/filing/0001209191-14-056122#line-3","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001492805","owner_name":"Palombella Vito J.","owner_display_name":"Palombella Vito J.","owner_url":"/insider/0001492805","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9472.0,"shares_display":"9,472","price_per_share":15.39,"price_display":"15.39","price_state":"stated","total_value":145774.08,"total_display":"145,774.08","total_whole":"145,774","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-03","filed_date":"2014-09-05","scope":"insider"},{"id":6876049,"accession":"0001209191-14-045478","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-045478","line_url":"/filing/0001209191-14-045478#line-2","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001492805","owner_name":"Palombella Vito J.","owner_display_name":"Palombella Vito J.","owner_url":"/insider/0001492805","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":879.0,"shares_display":"879","price_per_share":12.87,"price_display":"12.87","price_state":"stated","total_value":11312.73,"total_display":"11,312.73","total_whole":"11,313","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-01","filed_date":"2014-07-02","scope":"insider"},{"id":6788709,"accession":"0001209191-14-014851","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-014851","line_url":"/filing/0001209191-14-014851#line-2","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001492805","owner_name":"Palombella Vito J.","owner_display_name":"Palombella Vito J.","owner_url":"/insider/0001492805","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4736.0,"shares_display":"4,736","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":71040.0,"total_display":"71,040.00","total_whole":"71,040","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-25","filed_date":"2014-02-27","scope":"insider"},{"id":7081817,"accession":"0001181431-14-001309","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-001309","line_url":"/filing/0001181431-14-001309#line-2","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001492805","owner_name":"Palombella Vito J.","owner_display_name":"Palombella Vito J.","owner_url":"/insider/0001492805","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":753.0,"shares_display":"753","price_per_share":13.52,"price_display":"13.52","price_state":"stated","total_value":10180.56,"total_display":"10,180.56","total_whole":"10,181","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-02","filed_date":"2014-01-06","scope":"insider"},{"id":4915204,"accession":"0001181431-13-051135","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-051135","line_url":"/filing/0001181431-13-051135#line-2","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001492805","owner_name":"Palombella Vito J.","owner_display_name":"Palombella Vito J.","owner_url":"/insider/0001492805","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4736.0,"shares_display":"4,736","price_per_share":17.2797,"price_display":"17.28","price_state":"stated","total_value":81836.6592,"total_display":"81,836.66","total_whole":"81,837","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-27","filed_date":"2013-09-30","scope":"insider"},{"id":5204674,"accession":"0001181431-13-036288","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-036288","line_url":"/filing/0001181431-13-036288#line-2","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001492805","owner_name":"Palombella Vito J.","owner_display_name":"Palombella Vito J.","owner_url":"/insider/0001492805","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23150.0,"shares_display":"23,150","price_per_share":18.5342,"price_display":"18.53","price_state":"stated","total_value":429066.73,"total_display":"429,066.73","total_whole":"429,067","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-20","filed_date":"2013-06-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001718108","name":"Surface Oncology, Inc.","url":"/issuer/0001718108","role":"Officer (Chief Scientific Officer)","n_filings":2,"first_seen":"2022-01-14","last_seen":"2022-08-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001113148","name":"INFINITY PHARMACEUTICALS, INC.","url":"/issuer/0001113148","role":"Officer (Chief Scientific Officer)","n_filings":9,"first_seen":"2013-06-21","last_seen":"2015-06-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001492805","retrieved_at":"2026-08-22T20:57:07+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}